AbbVie ABBV is set to report first-quarter 2026 results on April 29, before the opening bell. While the immunology segment is ...

The clock isn’t going to slow down. The system isn’t going to fix itself. Here’s how clinicians are finding a way to live — ...

A small conference study sparked headlines linking fruit to lung cancer. Here’s why the science tells a very different story.

Patients with early‑onset lung cancer reported eating significantly more fruits, vegetables and whole grains.

While Merck’s PD-1/VEGF asset appears to match the performance of Summit Therapeutics’ ivonescimab, the pharma’s Phase 1/2 ...

Surgery for early-stage NSCLC is associated with similarly favorable safety and long-term outcomes for octogenarians and for younger patients.

Featured at this year’s meeting on early cancer research were results from an immunotherapy Merck acquired in 2024 and ...